http://arizona.technologypublisher.comBe the first to know about the latest inventions and technologies available from The University of Arizonaen-USWed, 10 Mar 2010 12:15:42 GMTWed, 10 Feb 2010 11:51:42 GMThttp://blogs.law.harvard.edu/tech/rssldemasque@ott.arizona.eduCopyright 2010, University of Arizonahttp://arizona.technologypublisher.com/technology/4584Wed, 10 Feb 2010 11:51:42 GMTldemasque@ott.arizona.eduhttp://arizona.technologypublisher.com/technology/4584http://arizona.technologypublisher.com/technology/4552Mon, 08 Feb 2010 14:34:13 GMTldemasque@ott.arizona.eduhttp://arizona.technologypublisher.com/technology/4552http://arizona.technologypublisher.com/technology/4545Fri, 05 Feb 2010 08:52:14 GMTldemasque@ott.arizona.eduhttp://arizona.technologypublisher.com/technology/4545http://arizona.technologypublisher.com/technology/3562Thu, 05 Nov 2009 07:51:35 GMTldemasque@ott.arizona.eduhttp://arizona.technologypublisher.com/technology/3562http://arizona.technologypublisher.com/technology/3557Tue, 03 Nov 2009 10:08:55 GMTldemasque@ott.arizona.eduhttp://arizona.technologypublisher.com/technology/3557http://arizona.technologypublisher.com/technology/3556Mon, 02 Nov 2009 12:14:25 GMTldemasque@ott.arizona.eduhttp://arizona.technologypublisher.com/technology/3556http://arizona.technologypublisher.com/technology/3474Background: Diffuse Large B Cell Lymphoma (DLBCL), which accounts for 35% of all cases of lymphoma, is a heterogeneous disease with variable patient survival. Gene expression profiling studies of DLBCL, performed by four different research groups (Rosenwald, et al, 2002; Tome, et al, 2005; Shipp et al, 2002; Lossos, et al, 2004) have identified largely non-overlapping gene sets associated with patient survival. No side-by-side studies have been published to date. These conflicting data make it difficult to determine which genes have prognostic significance. For example, one study found...Tue, 29 Sep 2009 11:57:02 GMTldemasque@ott.arizona.eduhttp://arizona.technologypublisher.com/technology/3474http://arizona.technologypublisher.com/technology/3473Background: Many mutations and drug compounds affect neural function by altering the shape and density of neuron networks, changes that can easily be seen by analyzing still images of prepared neuron cultures that have been genetically altered or exposed to experimental compounds. Drug discovery for developmental brain disorders lags decades behind that in other conditions, however, largely because existing cell-based screening assays are laborious to analyze accurately. A new software application, NeuronMetrics, can greatly improve the speed and accuracy of neuron-culture image analys...Tue, 29 Sep 2009 11:57:01 GMTldemasque@ott.arizona.eduhttp://arizona.technologypublisher.com/technology/3473http://arizona.technologypublisher.com/technology/3472Background: Immunoassays are used widely for detecting substances due to the specificity and ease of using antibodies. These properties have lead to immunoassay application in a variety of diverse industries including as clinical diagnosis, food contamination, environmental surveying, basic scientific research, and drug discovery. Numerous improvements have been made to make antibody based detection more sensitive (ELISA, RIA, and the like) but sensitivity and detection of the antigen-antibody interaction limit utility. Also, current immunoassays have not been adapted to microscale suc...Tue, 29 Sep 2009 11:57:01 GMTldemasque@ott.arizona.eduhttp://arizona.technologypublisher.com/technology/3472http://arizona.technologypublisher.com/technology/3471Tue, 29 Sep 2009 11:57:01 GMTldemasque@ott.arizona.eduhttp://arizona.technologypublisher.com/technology/3471http://arizona.technologypublisher.com/technology/3470Background: The field of information and computer technology is reaching a strategic inflection point, where a number of changes need to come together at the same time. One of these changes is the eventual end of the exponential growth of chip density, and the other is of high availability, fault-tolerance, and maintainability of information computing technology systems. We envision a scientific and technological revolution in the field of computer and information technology through a synergistic multidisciplinary research and training approach that will combine computer engineering an...Tue, 29 Sep 2009 11:57:00 GMTldemasque@ott.arizona.eduhttp://arizona.technologypublisher.com/technology/3470http://arizona.technologypublisher.com/technology/3462Fri, 25 Sep 2009 14:29:07 GMTldemasque@ott.arizona.eduhttp://arizona.technologypublisher.com/technology/3462http://arizona.technologypublisher.com/technology/3457Fri, 25 Sep 2009 10:41:54 GMTldemasque@ott.arizona.eduhttp://arizona.technologypublisher.com/technology/3457http://arizona.technologypublisher.com/technology/3434Background: The current knowledge of the pathogenesis and potential immunity for necrotic enteritis is greatly limited by the lack of a reliable experimental model. Current models are based upon the spontaneous occurrence of the disease as a result of feeding patterns or various methods of experimental inoculation with Clostridium perfringens yielding a low rate of lesion formation. In fact, most of these models fail to produce detectable lesions of necrotic enteritis greatly hampering the collection of data. The creation of a reliable animal model for necrotic enteritis would enable r...Tue, 15 Sep 2009 15:30:03 GMTldemasque@ott.arizona.eduhttp://arizona.technologypublisher.com/technology/3434http://arizona.technologypublisher.com/technology/3433Background: Small, unmethylated stretches of DNA called CpG islands, made up of cytosine and guanine repeats, are located next to housekeeping genes essential for cellular function. These, when positioned next to the promoter region of tumor suppression genes, can become abnormally methylated resulting in the formation of cancerous cells. Identification of these methylated CpG islands will aid in the diagnosis of human carcinomas. Applications:*Identifies specific DNA sequences containing subtle chemical modifications*Can be used for medical diagnosic purposes in various forms of cance...Tue, 15 Sep 2009 15:30:03 GMTldemasque@ott.arizona.eduhttp://arizona.technologypublisher.com/technology/3433http://arizona.technologypublisher.com/technology/3431Tue, 15 Sep 2009 15:30:03 GMTldemasque@ott.arizona.eduhttp://arizona.technologypublisher.com/technology/3431http://arizona.technologypublisher.com/technology/3430Background: Clostridium difficile-associated disease (CDAD) is of importance to humans, and is also a major cause of neonatal enteritis in pigs. Antimicrobials disrupt the normal flora of the colon allowing ingested spores to germinate freely. Piglets 1 to 7 days of age are infected resulting with gross lesions, mesocolonic edema and constipation. A recent study concluded that nearly one third of piglets with enteritis have been infected with C. difficile. This, combined with the importance of CDAD in humans, has brought about the need for a detailed examination of the organism includi...Tue, 15 Sep 2009 15:30:02 GMTldemasque@ott.arizona.eduhttp://arizona.technologypublisher.com/technology/3430http://arizona.technologypublisher.com/technology/3429 Background: Turmeric, the powdered rhizome of the herb Curcuma longa L. (Zingiberaceae), has been used in Ayurvedic medicine for over 4000 years to treat inflammation, skin wounds and tumors. Turmeric extracts have been reported to have antimicrobial, anti-inflammatory, antioxidant, and anticancer effects. Powdered turmeric, or its extract, is now found in numerous commercially available botanical supplements. The best characterized of the compounds found in turmeric is curcumin, which has been shown to reduce inflammation. While the sites of action and activity of curcumin have been ...Tue, 15 Sep 2009 15:30:01 GMTldemasque@ott.arizona.eduhttp://arizona.technologypublisher.com/technology/3429http://arizona.technologypublisher.com/technology/3424Fri, 11 Sep 2009 14:07:46 GMTldemasque@ott.arizona.eduhttp://arizona.technologypublisher.com/technology/3424http://arizona.technologypublisher.com/technology/3423Fri, 11 Sep 2009 09:48:57 GMTldemasque@ott.arizona.eduhttp://arizona.technologypublisher.com/technology/3423http://arizona.technologypublisher.com/technology/3422Fri, 11 Sep 2009 09:48:56 GMTldemasque@ott.arizona.eduhttp://arizona.technologypublisher.com/technology/3422http://arizona.technologypublisher.com/technology/3413Thu, 10 Sep 2009 10:18:39 GMTldemasque@ott.arizona.eduhttp://arizona.technologypublisher.com/technology/3413http://arizona.technologypublisher.com/technology/3412Thu, 10 Sep 2009 08:42:17 GMTldemasque@ott.arizona.eduhttp://arizona.technologypublisher.com/technology/3412http://arizona.technologypublisher.com/technology/3411Tue, 08 Sep 2009 13:06:20 GMTldemasque@ott.arizona.eduhttp://arizona.technologypublisher.com/technology/3411http://arizona.technologypublisher.com/technology/3410Tue, 08 Sep 2009 13:06:20 GMTldemasque@ott.arizona.eduhttp://arizona.technologypublisher.com/technology/3410